Loading candles…
Speciality Medicines Limited, incorporated in 2021, operates in the pharmaceutical industry with a focus on the marketing and distribution of finished formulations of speciality pharmaceuticals. The company is involved in the development and commercialization of specialty pharmaceutical products, emphasizing clinical development to provide treatment options supported by scientific data. It builds dedicated front-end infrastructure to ensure efficient product availability and facilitates direct engagement with healthcare professionals. The company's operations target regulated and global markets. There are no publicly listed subsidiaries or ventures associated with Speciality Medicines Limited, and no information about founders or key management has been provided.
This page is a live market overview for SPECIALITY MEDICINES LIMITED (SPML) on the BSE. As a listed security, SPECIALITY MEDICINES LIMITED is tracked in the Equities segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SPML before placing trades on tick2trade.
As of the latest feed, SPML last traded at ₹140 on BSE, down ₹2 (1.41%) from the previous close of ₹142. Today's session range is ₹140 – ₹141, against a 52-week band of ₹140 – ₹141. Traded volume today stands at 3.00K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for SPML in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SPML is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for SPECIALITY MEDICINES LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SPML. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SPML option chain page linked from this overview.
| Monthly F&O expiry |
| 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.
The accounts listed under Official handles are the only social media accounts operated by Tick2trade / Besseggen InfoTech LLP. We do not provide trading tips, stock recommendations or assured-return schemes, and we never ask for your login details, OTPs or payments over social media or messaging apps. Any other account, group or channel using our name is not associated with us; please report it to support@tick2trade.com.